Biological agents with potential for misuse: a historical perspective and defensive measures

被引:30
作者
Bhalla, DK [1 ]
Warheit, DB
机构
[1] Wayne State Univ, Eugene Applebaum Coll Pharm Hlth Sci, Dept Fundamental & Appl Sci, Detroit, MI 48202 USA
[2] DuPont Haskell Lab Hlth & Enivronm Sci, Newark, DE USA
关键词
biolovical agents; anthrax; smallpox;
D O I
10.1016/j.taap.2004.03.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Biological and chemical agents capable of producing serious illness or mortality have been used in biowarfare from ancient times. Use of these agents has progressed from crude forms in early and middle ages, when snakes and infected cadavers were used as weapons in battles, to sophisticated preparations for use during and after the second World War. Cults and terrorist organizations have attempted the use of biological agents with an aim to immobilize populations or cause serious harm. The reasons for interest in these agents by individuals and organizations include relative ease of acquisition, potential for causing mass casualty or panic, modest financing requirement, availability of technology, and relative ease of delivery. The Centers for Disease Control and Prevention has classified Critical Biological Agents into three major categories. This classification was based on several criteria, which include severity of impact on human health, potential for delivery in a weapon, capacity to cause panic and special needs for development, and stockpiling of medication. Agents that could cause the greatest harm following deliberate use were placed in category A. Category B included agents capable of producing serious harm and significant mortality but of lower magnitude than category A agents. Category C included emerging pathogens that could be developed for mass dispersion in future and their potential as a major health threat. A brief description of the category A bioagents is included and the pathophysiology of two particularly prominent agents, namely anthrax and smallpox, is discussed in detail. The potential danger from biological agents and their ever increasing threat to human populations have created a need for developing technologies for their early detection, for developing treatment strategies, and for refinement of procedures to ensure survival of affected individuals so as to attain the ultimate goal of eliminating the threat from intentional use of these agents. International treaties limiting development and proliferation of weapons and continuing development of defense strategies and safe guards against agents of concern are important elements of plans for eliminating this threat. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:71 / 84
页数:14
相关论文
共 61 条
  • [1] BEHAVIORAL-EFFECTS OF TULAREMIA AND SANDFLY FEVER IN MAN
    ALLUISI, EA
    BEISEL, WR
    BARTELLONI, PJ
    COATES, GD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1973, 128 (06) : 710 - 717
  • [2] Botulinum toxin as a biological weapon - Medical and public health management
    Arnon, SS
    Schechter, R
    Inglesby, TV
    Henderson, DA
    Bartlett, JG
    Ascher, MS
    Eitzen, E
    Fine, AD
    Hauer, J
    Layton, M
    Lillibridge, S
    Osterholm, MT
    O'Toole, T
    Parker, G
    Perl, TM
    Russell, PK
    Swerdlow, DL
    Tonat, K
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (08): : 1059 - 1070
  • [3] Bioterrorism: From threat to reality
    Atlas, RM
    [J]. ANNUAL REVIEW OF MICROBIOLOGY, 2002, 56 : 167 - 185
  • [4] Bioterrorism before and after September 11
    Atlas, RM
    [J]. CRITICAL REVIEWS IN MICROBIOLOGY, 2001, 27 (04) : 355 - 379
  • [5] Hemorrhagic fever viruses as biological weapons - Medical and public health management
    Borio, L
    Inglesby, T
    Peters, CJ
    Schmaljohn, AL
    Hughes, JM
    Jahrling, PB
    Ksiazek, T
    Johnson, KM
    Meyerhoff, A
    O'Toole, T
    Ascher, MS
    Bartlett, J
    Breman, JG
    Eitzen, EM
    Hamburg, M
    Hauer, J
    Henderson, A
    Johnson, RT
    Kwik, G
    Layton, M
    Lillibridge, S
    Nabel, GJ
    Osterholm, MT
    Perl, TM
    Russell, P
    Tonat, K
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (18): : 2391 - 2405
  • [6] Caudle L.C., 1997, Medical aspects of chemical, P451
  • [7] Centers for Disease Control and Prevention, 1998, MMWR MORB MORTAL WKL, V48, P69
  • [8] Biological warfare - A historical perspective
    Christopher, GW
    Cieslak, TJ
    Pavlin, JA
    Eitzen, EM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (05): : 412 - 417
  • [9] *CIDRAP, 2003, CTR INF DIS RES POL
  • [10] Dacko A, 2003, CUTIS, V71, P319